Santonja, Angela
Cooper, Wendy N https://orcid.org/0000-0003-3416-9982
Eldridge, Matthew D https://orcid.org/0000-0002-5799-8911
Edwards, Paul A W https://orcid.org/0000-0002-4789-3374
Morris, James A
Edwards, Abigail R
Zhao, Hui
Heider, Katrin https://orcid.org/0000-0003-4035-1668
Couturier, Dominique‐Laurent
Vijayaraghavan, Aadhitthya https://orcid.org/0000-0002-6095-8961
Mennea, Paulius
Ditter, Emma‐Jane https://orcid.org/0000-0003-0625-7264
Smith, Christopher G
Boursnell, Chris
Manzano García, Raquel https://orcid.org/0000-0002-5124-8992
Rueda, Oscar M
Beddowes, Emma
Biggs, Heather
Sammut, Stephen‐John https://orcid.org/0000-0003-4472-904X
Rosenfeld, Nitzan https://orcid.org/0000-0002-2825-4788
Caldas, Carlos https://orcid.org/0000-0003-3547-1489
Abraham, Jean E https://orcid.org/0000-0003-0688-4807
Gale, Davina https://orcid.org/0000-0002-4521-8199
Funding for this research was provided by:
Addenbrooke's Charitable Trust, Cambridge University Hospitals (ACT 9800)
AstraZeneca (A093777)
Cancer Research UK (C507/A27657)
Cancer Research UK (CRUKE/14/048)
Cancer Research UK (C36857/A27548)
Cancer Research UK (C1287/A26886)
Cancer Research UK (C17918/A28870)
Cancer Research UK (EDDCPT\100013)
EC | FP7 | Ideas | FP7 Ideas: European Research Council (337905)
Mark Foundation For Cancer Research (C9685/A25177)
NIHR | NIHR Cambridge Biomedical Research Centre (BRC‐1215‐20014)
University of Cambridge | Cancer Research UK Cambridge Institute, University of Cambridge (A20240)
University of Cambridge | Cancer Research UK Cambridge Institute, University of Cambridge (C9545/A29580)
Wellcome Trust (106566/Z/14/Z)
Article History
Received: 28 June 2022
Revised: 5 April 2023
Accepted: 6 April 2023
First Online: 10 May 2023